| UniProt ID | CY24B_HUMAN | |
|---|---|---|
| UniProt AC | P04839 | |
| Protein Name | Cytochrome b-245 heavy chain | |
| Gene Name | CYBB {ECO:0000312|HGNC:HGNC:2578} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 570 | |
| Subcellular Localization |
Cell membrane Multi-pass membrane protein. |
|
| Protein Description | Critical component of the membrane-bound oxidase of phagocytes that generates superoxide. It is the terminal component of a respiratory chain that transfers single electrons from cytoplasmic NADPH across the plasma membrane to molecular oxygen on the exterior. Also functions as a voltage-gated proton channel that mediates the H(+) currents of resting phagocytes. It participates in the regulation of cellular pH and is blocked by zinc.. | |
| Protein Sequence | MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 41 | Phosphorylation | DIPPKFFYTRKLLGS CCCCHHHCHHHHHHH | 14.57 | - | |
| 42 | Phosphorylation | IPPKFFYTRKLLGSA CCCHHHCHHHHHHHH | 19.03 | - | |
| 44 | Ubiquitination | PKFFYTRKLLGSALA CHHHCHHHHHHHHHH | 40.02 | 21906983 | |
| 88 | Phosphorylation | GSSACCSTRVRRQLD CCCHHCHHHHHHHHH | 21.19 | 24719451 | |
| 132 | N-linked_Glycosylation | WCVNARVNNSDPYSV HHEECCCCCCCCCCE | 36.41 | 19159218 | |
| 149 | N-linked_Glycosylation | SELGDRQNESYLNFA HHHCCCCCHHHHHHH | 40.87 | 19159218 | |
| 168 | Phosphorylation | KNPEGGLYLAVTLLA CCCCCHHHHHHHHHH | 8.90 | - | |
| 178 | Phosphorylation | VTLLAGITGVVITLC HHHHHHHHHHHHHHH | 24.01 | 22210691 | |
| 193 | Phosphorylation | LILIITSSTKTIRRS HHHHHHCCCCHHHHH | 25.85 | 22210691 | |
| 194 | Phosphorylation | ILIITSSTKTIRRSY HHHHHCCCCHHHHHH | 31.79 | 22210691 | |
| 240 | N-linked_Glycosylation | AESLAVHNITVCEQK HHHHHCCCEEEEEEH | 25.65 | 19159218 | |
| 253 | Ubiquitination | QKISEWGKIKECPIP EHHHHCCCCCCCCCC | 52.24 | - | |
| 294 | Ubiquitination | RFWRSQQKVVITKVV HHHHHCCCEEEEEEE | 30.72 | - | |
| 298 | Phosphorylation | SQQKVVITKVVTHPF HCCCEEEEEEECCCC | 13.23 | 19764811 | |
| 313 | 2-Hydroxyisobutyrylation | KTIELQMKKKGFKME CEEEEEEHHCCCEEE | 38.07 | - | |
| 324 | Phosphorylation | FKMEVGQYIFVKCPK CEEEECEEEEEECCC | 7.15 | - | |
| 334 | Ubiquitination | VKCPKVSKLEWHPFT EECCCCCEEEEECEE | 54.11 | - | |
| 418 | Phosphorylation | IGVTPFASILKSVWY CCCCCHHHHHHHHHH | 28.91 | 24719451 | |
| 486 | Phosphorylation | YLTGWDESQANHFAV EEECCCHHHHCEEEE | 31.92 | - | |
| 545 | Phosphorylation | GPEALAETLSKQSIS CHHHHHHHHHHHCCC | 30.63 | 28857561 | |
| 548 | Ubiquitination | ALAETLSKQSISNSE HHHHHHHHHCCCCCC | 51.70 | - | |
| 552 | Phosphorylation | TLSKQSISNSESGPR HHHHHCCCCCCCCCC | 39.28 | 23532336 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CY24B_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CY24B_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| ACTB_HUMAN | ACTB | physical | 16179592 |
| Kegg Disease | |
|---|---|
| H00098 | Chronic granulomatous disease, including the following four diseases: X-linked CGD (gp91 phox CGD); |
| H01167 | Gluconobacter infection |
| OMIM Disease | |
| 306400 | Granulomatous disease, chronic, X-linked (CGD) |
| 300645 | Immunodeficiency 34 (IMD34) |
| Kegg Drug | |
| There are no disease associations of PTM sites. | |
| DrugBank | |
| DB00514 | Dextromethorphan |
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-132; ASN-149 AND ASN-240,AND MASS SPECTROMETRY. | |